Faknostics LLC
Phoenix, AZ Faknostics, LLC
- UEI
- TK5AKDP8CSZ7
- CAGE
- 85VE1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 850 N 5th St #545, Phoenix, AZ 85004, USA
- Website
- faknostics.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel paxillin-FAK inhibitors for the treatment of liver fibrosis - abstract chronic liver diseases like metabolic… | National Institute of Diabetes and Digestive and Kidney Diseases | $2,654,655 | |
| Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis - project abstract idiopathic pulmonary fibrosis… | National Heart Lung and Blood Institute | $1,337,106 | |
| Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis - project abstract idiopathic pulmonary fibrosis… | National Heart Lung and Blood Institute | $599,810 | |
| Discovery of novel peptidic inhibitors of the non-catalytic function of focal adhesion kinase (FAK) | National Cancer Institute | $282,482 | |
| Development of non-catalytic peptide inhibitors of focal adhesion kinase (FAK) for use in melanoma - abstract melanoma… | National Cancer Institute | $4,026,942 |
About Faknostics LLC
Faknostics LLC is a woman-owned small business registered in SAM.gov since September 2018, specializing in biomedical research and development with a focused approach on developing novel peptide-based inhibitors targeting specific protein interactions in fibrotic disease conditions. The Phoenix, Arizona-based limited liability partnership operates primarily in the biotechnology and pharmaceutical research sector, focusing on developing innovative therapeutic approaches for complex medical challenges.
The company has been awarded multiple federal grants from prominent health research agencies, specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Heart Lung and Blood Institute (NHLBI). Their primary research efforts concentrate on developing non-catalytic FAK (Focal Adhesion Kinase) inhibitors as potential treatments for fibrotic conditions, including liver fibrosis and idiopathic pulmonary fibrosis (IPF). Recent grant awards, such as R42DK141379 and R42HL162392, support their research into developing stapled peptide-based inhibitors that target specific protein domain interactions. These grants, totaling approximately $651,952, demonstrate Faknostics' commitment to advancing therapeutic interventions for chronic diseases by exploring innovative molecular approaches that could potentially modify disease progression in conditions like liver fibrosis and lung fibrosis where current treatment options are limited.
SBA capabilities narrative
A comprehensive cancer diagnostics and therapeutics company based on a critical protein for cancer development and survival, Focal Adhesion Kinase (FAK).
Quick answers
What is Faknostics LLC's UEI?
Faknostics LLC's Unique Entity ID (UEI) in SAM.gov is TK5AKDP8CSZ7.
What is Faknostics LLC's CAGE code?
Faknostics LLC's CAGE code is 85VE1.
What is Faknostics LLC's primary NAICS code?
Faknostics LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Faknostics LLC located?
Faknostics LLC's physical address in SAM.gov is 850 N 5th St #545, Phoenix, AZ 85004, USA.
Is Faknostics LLC registered in SAM.gov?
Yes. Faknostics LLC's SAM.gov registration is active through August 18, 2027.
What is Faknostics LLC's most recent federal award?
Faknostics LLC's most recent federal grant award is Novel paxillin-FAK inhibitors for the treatment of liver fibrosis - abstract chronic liver diseases like metabolic… (R42DK141379), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 15, 2024.
On GovTribe
See Faknostics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors